arrow
W

Wolfgang E. Berdel

University Hospital Münster
H指数:98
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia

作者更正:组蛋白甲基转移酶EZH2的丢失诱导急性髓系白血病对多种药物的耐药性

2026-01-070
OAAI
Reduce bureaucracy in clinical trials now

减少临床试验中的官僚主义

2026-01-050
PRE
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients

4978例接受强化治疗的AML欧洲患者队列中,髓系发育异常相关基因突变的不同预后影响

Leukemia
IF13.4
2025-10-270
OA
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

跨大陆成人急性髓系白血病的多维分析揭示了突变景观和治疗结局中的年龄相关趋势(Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

Leukemia
IF13.4
2025-09-190
OAAI
Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia

生活质量和生活满意度在急性髓系白血病长期幸存者中

Leukemia
IF13.4
2025-08-220
OAAI
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial

疾病风险而非缓解状态决定了AML的移植结局:ASAP试验的长期结局

Blood
IF23.1
2025-08-050
OAAI
Photodynamic ROS inducers delivered via electrostatic antibody targeted (ELART) nanocarriers incorporate into tumour cells and inhibit colony growth

通过静电抗体靶向(ELART)纳米载体递送的 photodynamic ROS 诱导剂可整合到肿瘤细胞中并抑制集落生长

2025-01-010
OA
Improving risk stratification for 2022 European LeukemiaNet favorable- risk patients with acute myeloid leukemia
2024-11-010
OAAI
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study

首次完全缓解的老年急性髓性白血病患者的造血细胞移植: 一项随机III期研究的结果

2024-08-081
OAAI
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens
2024-04-241
OAAI
Friday Leukemia-a Structural Phenomenon
2024-02-090
OA
Prognostic impact of CEBPA mutational subgroups in adult AML
LEUKEMIA
IF13.4
2024-01-165
OAAI
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)
LEUKEMIA
IF13.4
2023-11-289
OAAI
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
LEUKEMIA
IF13.4
2023-10-134
OAAI
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European leukemia net risk classification
LEUKEMIA
IF13.4
2023-09-0711
OAAI